Myocardial Revascularization in Patients with Metabolic Syndrome

• DOI: https://doi.org/10.22533/at.ed.1594962429101

• Palavras-chave: Myocardial Revascularization; Metabolic Syndrome; Coronary Artery Disease; Cardiovascular Surgical Procedures.

• Keywords: Myocardial Revascularization; Metabolic Syndrome; Coronary Artery Disease; Cardiovascular Surgical Procedures.

• Abstract:

  Introduction: Metabolic Syndrome (MS) is characterized by a set of interconnected metabolic alterations associated with an increased risk of cardiovascular disease and type 2 diabetes. These factors include hypertension, central obesity, dyslipidemia and glucose metabolism disorders, constituting a serious public health challenge. Metabolic syndrome increases the risk of cardiovascular disease and stroke 2-fold, as well as increasing the risk of all-cause mortality by 1.5-fold. Objective: This study aims to analyze the correlation between Metabolic Syndrome and the increased risk of cardiovascular disease. Methodology: The review was conducted in databases such as PubMed and Scopus, with inclusion criteria of clinical studies and systematic reviews. Data was extracted and analyzed to compare the effectiveness of different types of nerve blocks. Results and Discussion: Metabolic Syndrome (MS) is strongly associated with a significant increase in the risk of cardiovascular disease (CVD), stroke and mortality. People with MetS are twice as likely to develop CVD and stroke, and have a 1.5 times greater risk of death from any cause. Factors such as hypertension, central obesity, dyslipidemia and alterations in glucose metabolism are key components of this condition. Thus, MetS represents a major threat to global public health due to its complications. Conclusion: Metabolic Syndrome (MS) is linked to a high risk of cardiovascular disease, type 2 diabetes and surgical complications such as infections and thrombosis. Inflammatory and metabolic factors increase the chance of atherosclerosis, heart attacks and strokes. Preventive approaches and personalized therapies are essential to minimize complications and improve clinical outcomes.